Hemenway Trust Co LLC raised its stake in Stryker Corporation (NYSE:SYK) by 15.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,111 shares of the medical technology company’s stock after buying an additional 975 shares during the period. Hemenway Trust Co LLC’s holdings in Stryker Corporation were worth $987,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Bollard Group LLC boosted its position in shares of Stryker Corporation by 0.4% in the first quarter. Bollard Group LLC now owns 829 shares of the medical technology company’s stock valued at $109,000 after buying an additional 3 shares in the last quarter. Assetmark Inc. boosted its position in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock valued at $168,000 after buying an additional 4 shares in the last quarter. Blue Chip Partners Inc. boosted its position in shares of Stryker Corporation by 0.3% in the first quarter. Blue Chip Partners Inc. now owns 1,775 shares of the medical technology company’s stock valued at $234,000 after buying an additional 6 shares in the last quarter. Guardian Life Insurance Co. of America boosted its position in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock valued at $158,000 after buying an additional 9 shares in the last quarter. Finally, Baystate Wealth Management LLC boosted its position in shares of Stryker Corporation by 2.1% in the first quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock valued at $139,000 after buying an additional 22 shares in the last quarter. 73.79% of the stock is owned by institutional investors.

Stryker Corporation (NYSE SYK) traded down 0.74% during midday trading on Friday, hitting $144.29. The stock had a trading volume of 1,673,285 shares. The stock has a market cap of $53.97 billion, a P/E ratio of 32.21 and a beta of 0.80. Stryker Corporation has a 52 week low of $106.48 and a 52 week high of $148.84. The company has a 50-day moving average price of $144.61 and a 200-day moving average price of $136.38.

Stryker Corporation (NYSE:SYK) last posted its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.02. The company had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The firm’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.39 EPS. Equities analysts expect that Stryker Corporation will post $6.50 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be paid a dividend of $0.425 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.70 annualized dividend and a dividend yield of 1.18%. Stryker Corporation’s payout ratio is 37.95%.

COPYRIGHT VIOLATION WARNING: “Stryker Corporation (SYK) Stake Boosted by Hemenway Trust Co LLC” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/19/stryker-corporation-syk-stake-raised-by-hemenway-trust-co-llc-updated.html.

Several equities analysts have recently weighed in on the stock. Zacks Investment Research cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Thursday. BidaskClub cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Jefferies Group LLC reissued a “hold” rating and issued a $132.00 target price on shares of Stryker Corporation in a research note on Friday, June 30th. Barclays PLC reissued a “sell” rating and issued a $133.00 target price on shares of Stryker Corporation in a research note on Thursday, April 27th. Finally, Oppenheimer Holdings, Inc. set a $148.00 target price on shares of Stryker Corporation and gave the company a “hold” rating in a research note on Friday, July 28th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $144.03.

In related news, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $146.36, for a total transaction of $731,800.00. Following the sale, the insider now owns 88,207 shares of the company’s stock, valued at approximately $12,909,976.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the sale, the insider now directly owns 8,983 shares in the company, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. Insiders have sold a total of 32,810 shares of company stock valued at $4,754,958 in the last quarter. 7.40% of the stock is owned by corporate insiders.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.